LENSAR, Inc. (LNSR)
Nasdaq: LNSR · Surgical & Medical Instruments & Apparatus · Orlando, FL · filing with the SEC since 2005
Who owns LENSAR, Inc.
As filed with the SECHolders of 5% or more
3
Ellis Thomas B holds 55.9% of Common Stock, $0.01 par value, as its SCHEDULE 13D/A filed Mar 25, 2025 says.
Directors and officers
12
report now, of 13 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Ellis Thomas B
SCHEDULE 13D/A · filed Mar 25, 2025 · Common Stock, $0.01 par value
Brandes Investment Partners, LP
SCHEDULE 13G/A · filed May 14, 2026 · Common Shares · 6.5% in Nov 13, 2025
Nicholas T. Curtis
SCHEDULE 13G/A · filed May 13, 2025 · Common Stock, par value $0.01
Dimensional Fund Advisors LP
SCHEDULE 13G/A · filed Apr 15, 2025 · Common Stock · reported falling below 5%
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 29, 2026 · Common Stock · reported falling below 5%, from 5.2% in Oct 17, 2025
Park West Asset Management LLC
SCHEDULE 13G/A · filed May 15, 2025 · COMMON STOCK, PAR VALUE $0.01 PER SHARE · reported falling below 5%, from 7% in Feb 14, 2025
What LNSR reports owning in othersstakes of 5% or more, and other ties
LENSAR, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.